Molecular Diagnosis and Regulation of Mitochondrial Dysfunction

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: 30 June 2024 | Viewed by 148

Special Issue Editor


E-Mail Website
Guest Editor
Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA
Interests: mechanisms of mitochondrial dysfunction in autism, fragile X tremor and ataxia syndrome

Special Issue Information

Dear Colleagues,

The goal of the call for "Molecular Diagnosis and Regulation of Mitochondrial Dysfunction" is to promote and advance scientific research in understanding and addressing issues related to mitochondrial dysfunction, a critical area of study in the field of molecular biology and biochemistry. Mitochondria play a central role in energy production and various cellular processes, and their dysfunction is associated with a wide range of diseases, including neurodegenerative disorders, metabolic diseases and cancer. This call seeks to encourage researchers to investigate the molecular mechanisms underlying mitochondrial dysfunction and develop innovative approaches for its diagnosis and regulation. Ultimately, the aim is to contribute to the development of novel therapeutic strategies and diagnostic tools that can improve the quality of life for individuals affected by mitochondrial-related conditions.

Dr. Cecilia Giulivi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic conditions
  • neurological conditions
  • genetic diseases
  • mitochondrial dysfunction
  • mitochondrial disorders
  • diagnostics
  • therapies

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Review Title: Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease (COPD): Unraveling the Molecular Nexus
Author: Liu
Highlights: 1. COPD & Mitochondrial Dysfunction: Uncover the link between Chronic Obstructive Pulmonary Disease and mitochondrial abnormalities. 2. Molecular Insights: Explore respiratory chain disruptions, altered dynamics, and quality control mechanisms impacting cellular homeostasis. 3. Pathological Crosstalk: Investigate the interplay of dysfunctional mitochondria with inflammation and senescence, influencing COPD progression. 4. Therapeutic Prospects: Discuss potential interventions targeting mitochondrial dysfunction for enhanced COPD management and prognosis.

Back to TopTop